[1]
C. Sanchez Aranda, K. M. Costa Silvestre, K. da Silva Marques, M. Lucia Lee, and D. Solé, “Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens–Johnson syndrome”, Allergol Immunopathol, vol. 52, no. 4, pp. 81–83, Jul. 2024, doi: 10.15586/aei.v52i4.983.